Literature DB >> 19935413

Complications of seasonal and pandemic influenza.

Michael B Rothberg1, Sarah D Haessler.   

Abstract

Influenza is a seasonal viral infection associated with significant morbidity and mortality. In 2009, a novel H1N1 influenza A virus emerged and has been classified as a pandemic. In contrast to seasonal influenza, severe disease from pandemic H1N1 seems concentrated in older children and young adults, with almost no cases reported in patients older than 60 yrs. Although patients with underlying cardiopulmonary disease remain at risk, most complications have occurred among previously healthy individuals, with obesity and respiratory disease as the strongest risk factors. Pulmonary complications are common. Primary influenza pneumonia occurs most commonly in adults and may progress rapidly to acute lung injury requiring mechanical ventilation. Secondary bacterial infection is more common in children. Staphylococcus aureus, including methicillin-resistant strains, is an important cause of secondary bacterial pneumonia with a high mortality rate. Treatment of pneumonia should include empirical coverage for this pathogen. Neuromuscular and cardiac complications are unusual but may occur.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19935413     DOI: 10.1097/CCM.0b013e3181c92eeb

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  84 in total

1.  Impaired wound healing predisposes obese mice to severe influenza virus infection.

Authors:  Kevin B O'Brien; Peter Vogel; Susu Duan; Elena A Govorkova; Richard J Webby; Jonathan A McCullers; Stacey Schultz-Cherry
Journal:  J Infect Dis       Date:  2011-12-05       Impact factor: 5.226

2.  Long-term antibody and immune memory response induced by pulmonary delivery of the influenza Iscomatrix vaccine.

Authors:  Ana Vujanic; Kenneth J Snibson; Janet L K Wee; Stirling J Edwards; Martin J Pearse; Jean-Pierre Y Scheerlinck; Philip Sutton
Journal:  Clin Vaccine Immunol       Date:  2011-11-09

Review 3.  Pregnancy and pregnancy-associated hormones alter immune responses and disease pathogenesis.

Authors:  Dionne P Robinson; Sabra L Klein
Journal:  Horm Behav       Date:  2012-03-03       Impact factor: 3.587

4.  Persistence of immunogenicity of a monovalent influenza virus A/H1N1 2009 vaccine in healthy volunteers.

Authors:  Yi-Chun Lai; Kuen-Cheh Yang; Szu-Min Hsieh; Chien-An Yao; Long-Teng Lee; Kuo-Chin Huang
Journal:  Clin Vaccine Immunol       Date:  2012-01-18

Review 5.  Influenza-related pneumonia.

Authors:  Mark H Almond; Danny F McAuley; Matt P Wise; Mark J D Griffiths
Journal:  Clin Med (Lond)       Date:  2012-02       Impact factor: 2.659

6.  [The universal influenza vaccination in children with Vaxigrip Tetra® in Italy: an evaluation of Health Technology Assessment].

Authors:  Sara Boccalini; Angela Bechini; Maddalena Innocenti; Gino Sartor; Federico Manzi; Paolo Bonanni; Donatella Panatto; Piero Luigi Lai; Francesca Zangrillo; Emanuela Rizzitelli; Mariasilvia Iovine; Daniela Amicizia; Chiara Bini; Andrea Marcellusi; Francesco Saverio Mennini; Alessandro Rinaldi; Francesca Trippi; Anna Maria Ferriero; Giovanni Checcucci Lisi
Journal:  J Prev Med Hyg       Date:  2018-05-30

Review 7.  Influenza and the use of oseltamivir in children.

Authors:  Ergin Çiftçi; Adem Karbuz; Tanıl Kendirli
Journal:  Turk Pediatri Ars       Date:  2016-06-01

8.  A 3-month-old baby with H1N1 and Guillain-Barré syndrome.

Authors:  Alexandra Vasconcelos; Francisco Abecasis; Rita Monteiro; Cristina Camilo; Marisa Vieira; Mamede de Carvalho; Manuela Correia
Journal:  BMJ Case Rep       Date:  2012-03-27

Review 9.  Renal complications of seasonal and pandemic influenza A virus infections.

Authors:  Toru Watanabe
Journal:  Eur J Pediatr       Date:  2012-10-13       Impact factor: 3.183

Review 10.  Bench-to-bedside review: bacterial pneumonia with influenza - pathogenesis and clinical implications.

Authors:  Koenraad F van der Sluijs; Tom van der Poll; René Lutter; Nicole P Juffermans; Marcus J Schultz
Journal:  Crit Care       Date:  2010-04-19       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.